Result of AGM

Ananda Developments PLC
24 August 2023
 

24 August 2023

 

ANANDA DEVELOPMENTS PLC

("Ananda" or the "Company")

 

Result of Annual General Meeting

 

Ananda Developments plc (AQSE: ANA) is pleased to announce that at the Annual General Meeting of the Company held earlier today all resolutions were duly passed by shareholders.

 

Proxy votes were received as follows:

 

Resolution

Votes for

%

Votes against

%

Votes total

Votes withheld

Resolution 1

278,538,686

99.99%

26,192

0.01%

278,564,878

6,976

Resolution 2

278,256,362

99.98%

46,725

0.02%

278,303,087

268,767

Resolution 3

278,276,792

99.99%

26,295

0.01%

278,303,087

268,767

Resolution 4

278,256,362

99.98%

46,725

0.02%

278,303,087

268,767

Resolution 5

278,256,362

99.98%

46,725

0.02%

278,303,087

268,767

Resolution 6

278,538,583

99.99%

26,295

0.01%

278,564,878

6,976

Resolution 7

278,276,792

99.99%

26,295

0.01%

278,303,087

268,767

Resolution 8

278,276,792

99.99%

26,295

0.01%

278,303,087

268,767

Resolution 9

278,291,237

99.99%

26,295

0.01%

278,317,532

254,322

Resolution 10

278,276,792

99.98%

48,748

0.02%

278,325,540

254,322

Resolution 11

278,256,362

99.98%

48,748

0.02%

278,305,110

274,752

 

-Ends-

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

ANANDA DEVELOPMENTS PLC

+44 (0)7463 686 497


ir@anandadevelopments.com

Chief Executive Officer


Melissa Sturgess




Finance Director


Jeremy Sturgess-Smith




SP ANGEL CORPORATE FINANCE LLP

+44 (0)20 3470 0470



Corporate Finance


Richard Morrison


Harry Davies-Ball


 


Corporate Broking


Abigail Wayne


Rob Rees


 

 

About Ananda Developments

 

Ananda is an AQSE-listed company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of complex, chronic inflammatory pain conditions.

 

For more information, please visit: https://anandadevelopments.com/

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings